• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

缺血性脑血管疾病：多种抗血小板聚集药物治疗。80例患者的临床随访（22 - 34个月）

[Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)].

作者信息

Caneschi S, Bonaventi C, Finzi F

出版信息

Minerva Med. 1985 Oct 27;76(41):1933-43.

PMID:2865702
Abstract

Personal experience in the treatment of Ischaemic Cerebrovascular Disease with platelet suppressant drugs is reported. 80 patients were treated with 5 different protocols: 1) group "A": dipyridamol (14 patients); 2) group "B": acetylsalicylic acid (ASA) (14 patients); 3) group "C": dipyridamol and ASA (22 patients); 4) group "D": ditazol (15 patients); 5) group "E": isoxsuprine resinate (15 patients) and followed-up for 22-34 months. The evolution of the disease is discussed and recurrences evaluated on the basis of initial clinical features and particular treatment given.

摘要

报告了使用血小板抑制药物治疗缺血性脑血管疾病的个人经验。80例患者采用5种不同方案进行治疗：1）“A组”：双嘧达莫（14例患者）；2）“B组”：阿司匹林（ASA）（14例患者）；3）“C组”：双嘧达莫和ASA（22例患者）；4）“D组”：地他唑（15例患者）；5）“E组”：利栓灵（15例患者），并随访22 - 34个月。根据初始临床特征和所给予的特定治疗，对疾病的进展进行了讨论并对复发情况进行了评估。

相似文献

1
[Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)].缺血性脑血管疾病：多种抗血小板聚集药物治疗。80例患者的临床随访（22 - 34个月）
Minerva Med. 1985 Oct 27;76(41):1933-43.
2
[Ditazol in the therapy of ischemic cerebrovascular diseases. Clinical results and laboratory experiments (22-to-34-month clinical follow-up)].双嘧达莫在缺血性脑血管疾病治疗中的应用。临床结果与实验室实验（22至34个月临床随访）
Minerva Med. 1985 Oct 20;76(40):1883-94.
3
[Resinated isoxsuprine in the therapy of cerebral ischemic vascular diseases].[树脂化异舒普林在脑缺血性血管疾病治疗中的应用]
Minerva Med. 1984 Nov 30;75(45-46):2769-76.
4
Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.缺血性卒中抗血小板治疗期间血小板聚集的测量
Clin Hemorheol Microcirc. 2004;30(3-4):237-42.
5
Variable platelet response to aspirin in patients with ischemic stroke.缺血性中风患者对阿司匹林的血小板反应存在差异。
Cerebrovasc Dis. 2007;24(1):43-50. doi: 10.1159/000103115. Epub 2007 May 22.
6
Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.缓释双嘧达莫与低剂量阿司匹林固定剂量组合与氯吡格雷联合或不联合阿司匹林在2型糖尿病和短暂性脑缺血发作病史患者中的抗血小板谱：一项随机、单盲、30天试验。
Clin Ther. 2008 Feb;30(2):249-59. doi: 10.1016/j.clinthera.2008.02.006.
7
Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.用光学聚集法比较没食子酸丙酯阳离子与二磷酸腺苷用于测量阿司匹林有效性的研究
Transl Res. 2007 Oct;150(4):246-52. doi: 10.1016/j.trsl.2007.02.004. Epub 2007 May 25.
8
Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.冠心病患者中胶原蛋白与二磷酸腺苷在检测抗血小板作用方面的比较。
Biomed Pharmacother. 2009 Sep;63(8):608-12. doi: 10.1016/j.biopha.2008.10.004. Epub 2008 Oct 31.
9
[Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].[利用阳离子没食子酸丙酯诱导的血小板聚集评估来估计心血管并发症的复发情况]
Vnitr Lek. 2004 Aug;50(8):591-9.
10
Platelet emboli and ischemia in rabbit's brain caused by ADP or arachidonic acid and the protective effect of ASA and dipyridamole.ADP或花生四烯酸所致兔脑血小板栓子与缺血及阿司匹林和双嘧达莫的保护作用
Biochem Exp Biol. 1977;13(3):315-9.

引用本文的文献

1
Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.多种抗血小板药物与较少抗血小板药物预防缺血性卒中或短暂性脑缺血发作后早期复发的比较
Cochrane Database Syst Rev. 2020 Aug 17;8(8):CD009716. doi: 10.1002/14651858.CD009716.pub2.
2
Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.缺血性脑卒中的抗栓和溶栓治疗：《抗栓治疗与血栓预防，第 9 版》：美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e601S-e636S. doi: 10.1378/chest.11-2302.
3
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
双嘧达莫用于预防血管疾病患者的中风及其他血管事件。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD001820. doi: 10.1002/14651858.CD001820.pub3.